<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(4)</volume><submitter>Parisi B</submitter><pubmed_abstract>The C2C12 cell line represents a simple in vitro model for cell differentiation. Here, we present a flow-cytometry-based pipeline to quantitate C2C12 cell differentiation based on myosin heavy-chain marker expression. We describe steps for cell seeding, transfection, drug treatment, differentiation, and labeling. We then detail procedures for flow cytometry acquisition and introduce the R script FlowFate for automated analysis, including the study of dose-dependent effects of GFP-tagged genes on differentiation. For complete details on the use and execution of this protocol, please refer to Chippalkatti et al. (2023).&lt;sup>1&lt;/sup>.</pubmed_abstract><journal>STAR protocols</journal><pagination>102637</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10568640</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A flow-cytometry-based pipeline for the rapid quantification of C2C12 cell differentiation.</pubmed_title><pmcid>PMC10568640</pmcid><pubmed_authors>Parisi B</pubmed_authors><pubmed_authors>Sunnen M</pubmed_authors><pubmed_authors>Abankwa DK</pubmed_authors><pubmed_authors>Chippalkatti R</pubmed_authors></additional><is_claimable>false</is_claimable><name>A flow-cytometry-based pipeline for the rapid quantification of C2C12 cell differentiation.</name><description>The C2C12 cell line represents a simple in vitro model for cell differentiation. Here, we present a flow-cytometry-based pipeline to quantitate C2C12 cell differentiation based on myosin heavy-chain marker expression. We describe steps for cell seeding, transfection, drug treatment, differentiation, and labeling. We then detail procedures for flow cytometry acquisition and introduce the R script FlowFate for automated analysis, including the study of dose-dependent effects of GFP-tagged genes on differentiation. For complete details on the use and execution of this protocol, please refer to Chippalkatti et al. (2023).&lt;sup>1&lt;/sup>.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2025-04-22T11:03:18.84Z</modification><creation>2025-04-05T23:47:31.556Z</creation></dates><accession>S-EPMC10568640</accession><cross_references><pubmed>37819762</pubmed><doi>10.1016/j.xpro.2023.102637</doi></cross_references></HashMap>